Featured Research

from universities, journals, and other organizations

Finasteride reduces symptoms and disease progression associated with enlarged prostates, study finds

Date:
October 6, 2010
Source:
Wiley-Blackwell
Summary:
When compared with placebo and other drugs, long-term use of finasteride improves urinary tract symptoms associated with benign prostatic hyperplasia, and reduces disease progression. This conclusion comes from combining the findings of 23 randomized clinical trials that evaluated almost 21,000 men.

When compared with placebo and other drugs, long-term use of finasteride improves urinary tract symptoms associated with benign prostatic hyperplasia, and reduces disease progression. This conclusion comes from combining the findings of 23 randomized clinical trials that evaluated almost 21,000 men, and is published this month in The Cochrane Library.

Finasteride is frequently given to men who have lower urinary tract symptoms (LUTS) such as frequent voiding at night (nocturia), incomplete emptying, hesitancy, weak stream, and frequent and urgent urination. The symptoms are often caused by prostatic smooth-muscle contractions, and by benign prostatic hyperplasia, a non-cancerous condition in which the prostate gland grows too large.

Like many organs in the body, the size of the prostate is influenced by particular hormones. Dihydrotestosterone is one hormone that increases its size. Finasteride belongs to a class of drugs called 5 alpha reductase inhibitors (5ARI) that reduce prostate size. The full effects of how 5ARIs shrink the prostate are not fully understood, but in part they work by blocking the body's ability to make dihydrotestosterone.

Pharmacologic therapy is the most frequent way of treating men with moderate to severe LUTS and related symptoms. Drugs like finasteride are frequently prescribed to improve LUTS and reduce long-term symptom progression, including the risk for acute urinary retention and the need for surgical intervention. "We needed to determine the effectiveness and harms of finasteride when used on its own or in combination with other therapies, and to compare this with similar drugs," says study leader James Tacklind, who works at the Veterans Affairs Medical Center, Minneapolis, USA.

Finasteride was even more effective at lowering symptom scores when used in combination with doxazosin, an alpha blocker.

"Finasteride seems to be more effective in men with large prostates who use the drugs for at least 1 year, compared to those with small prostates," says Tacklind.

Looking at drug-related adverse effects, the researchers found that they were uncommon in men using finasteride; nevertheless, compared to placebo, men taking it are at slightly increased risk for impotence, erectile dysfunction, decreased libido, and ejaculation disorder.


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Journal Reference:

  1. James Tacklind, Howard A Fink, Roderick MacDonald, Indy Rutks, Timothy J Wilt. Finasteride for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews, 2010 (10): CD006015 DOI: 10.1002/14651858.CD006015.pub3

Cite This Page:

Wiley-Blackwell. "Finasteride reduces symptoms and disease progression associated with enlarged prostates, study finds." ScienceDaily. ScienceDaily, 6 October 2010. <www.sciencedaily.com/releases/2010/10/101006085236.htm>.
Wiley-Blackwell. (2010, October 6). Finasteride reduces symptoms and disease progression associated with enlarged prostates, study finds. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2010/10/101006085236.htm
Wiley-Blackwell. "Finasteride reduces symptoms and disease progression associated with enlarged prostates, study finds." ScienceDaily. www.sciencedaily.com/releases/2010/10/101006085236.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

House Republicans Vote to Sue Obama Over Healthcare Law

House Republicans Vote to Sue Obama Over Healthcare Law

Reuters - US Online Video (July 31, 2014) The Republican-led House of Representatives votes to sue President Obama, accusing him of overstepping his executive authority in making changes to the Affordable Care Act. Mana Rabiee reports. Video provided by Reuters
Powered by NewsLook.com
Despite Health Questions, E-Cigs Are Beneficial: Study

Despite Health Questions, E-Cigs Are Beneficial: Study

Newsy (July 31, 2014) Citing 81 previous studies, new research out of London suggests the benefits of smoking e-cigarettes instead of regular ones outweighs the risks. Video provided by Newsy
Powered by NewsLook.com
Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins